Filter Results
Clinical Studies
Results filtered:Study status:
Open
Contact Us for the Latest Status
Closed for Enrollment
Open
-
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM IN RELIEVING, INTERRUPTING, AND PREVENTING CHRONIC MIGRAINE (RELIEV-CM2) (RELIEV-CM2)
Rochester, Minn.,
Scottsdale/Phoenix, Ariz.
The purpose of this study is to evaluate the safety and efficacy of the ShiraTronics Migraine Therapy System.
-
A Prospective Feasibility Study Evaluating the Use of Wearable Devices to Predict and Track Clinical Outcomes in Chronic Migraine
Rochester, Minn.
The purpose of this study is to accurately track biomarkers of headache coupled with patient reporting of severity with minimal effort by the patient using a custom phone app integrating patient and devices. Also, to accurately forecast periods of increased headache likelihood to allow patients earlier and more effective treatments.
-
CAT-Trial: CGRP monoclonal Antibody for Treatment of painful diabetic neuropathy:
a double-blind, randomized, placebo-controlled, international multicenter, phase II clinical trial (CAT-Trial)
Rochester, Minn.
The purpose of this study is to compare the change in pain intensity during treatment with a CGRP monoclonal antibody (eptinezumab) compared with placebo treatment in patients with painful diabetic polyneuropathy (DPN).
-
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for Acute Headache in Aneurysmal Subarachnoid Hemorrhage (BLOCK-SAH)
Rochester, Minn.,
Jacksonville, Fla.
The purpose of this study is to assess the efficacy and safety of PPF-block to mitigate opiod use requirements and improve headache pain control in patients with aneurysmal SAH.
Contact Us for the Latest Status
.